Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018 · Journal of Hematology & Oncology · 790 citations
https://doi.org/10.1186/s13045-018-0582-8
K
Keith L. Knutson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
394
Papers
24.7K
Citations
64
h-index
147
i10-index
Keith L. Knutson is an academic researcher from Jacksonville College. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 64, co-authored 335 publications.
ORCID: 0000-0001-9932-4467Papers by this author
worksTumor antigen-specific T helper cells in cancer immunity and immunotherapy
2005 · Cancer Immunology Immunotherapy · 673 citations
https://doi.org/10.1007/s00262-004-0653-2
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
2001 · Journal of Clinical Investigation · 450 citations
https://doi.org/10.1172/jci11752
Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based Vaccines
2002 · Journal of Clinical Oncology · 425 citations
https://doi.org/10.1200/jco.2002.06.171
Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity.
2002 · PubMed · 232 citations
Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy
2007 · Clinical Cancer Research · 213 citations
https://doi.org/10.1158/1078-0432.ccr-07-0507
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat